Medulloblastoma, Childhood Clinical Trial
Official title:
Impact of Physical Activity on Postural Stability and Coordination in Children With Posterior Fossa Tumor
Verified date | August 2021 |
Source | Children's Cancer Hospital Egypt 57357 |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Medulloblastoma is a rapidly-growing tumor of the cerebellum, this area controls balance, posture and sophisticated motor functions like finer hand movements, speech, and swallowing. It has been reported that those children fall frequently so the purpose of this study is to investigate the effectiveness of balance and coordination training in these Children.
Status | Completed |
Enrollment | 60 |
Est. completion date | April 30, 2021 |
Est. primary completion date | April 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 5 Years to 12 Years |
Eligibility | Inclusion Criteria: 1. Children with posterior fossa tumors during follow up. 2. Children between 5-12 years old. 3. Time elapsed since the start of treatment more than 4 months in order to be in maintenance phase. 4. They can understand verbal command. 5. Children with no visual, auditory or perceptual disorders. 6. Children are already treated surgically. Exclusion Criteria: - Children who have one or more of the following criteria will be excluded from the study: 1. Children with a genetic disorder or mental retardation. 2. Children with a chronic lung disease. 3. Sever cardiomyopathy (ejection fraction <40%, ischemia and angina pectoris at rest). 4. Children with a neuromuscular disease not related to tumor. |
Country | Name | City | State |
---|---|---|---|
Egypt | Children's Cancer Hospital Egypt 57357 | Cairo |
Lead Sponsor | Collaborator |
---|---|
Children's Cancer Hospital Egypt 57357 |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change Balance | For assessment of the three groups, HUMAC balance and tilt system will be used to assess both Static and dynamic balance. | at week 12 | |
Secondary | Change Coordination | The Bruininks-Oseretsky Test of Motor Proficiency - Second Edition
- The minimum and maximum values: Coordination will be assessed using BOT2, Bilateral coordination (Sub test No.4) composed of 7 items and Upper-Limb coordination (Sub test No.7) composed of 7 items too. The raw scores are recorded first then it is converted into point scores, then subtest total point score is obtained by adding point scores. Bilateral Coordination: Total Point Score Subtest (min=Zero, max=24). Upper-Limb Coordination: Total Point Score Subtest (min=Zero, max=39). - Higher scores mean a better outcome. |
at week 12 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04167618 -
177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03288168 -
Children's and Adolescents' Medulloblastoma Molecular Subgroups in China
|
||
Recruiting |
NCT05298995 -
GD2-CAR T Cells for Pediatric Brain Tumours
|
Phase 1 | |
Recruiting |
NCT04174820 -
Child's Study of the Impact of PF Lesion on Motor Skills, Language, Cognitive Functioning and Social Cognition
|
||
Completed |
NCT04860934 -
Dual Task Training On Children With Ataxia After Medulloblastoma Resection
|
N/A | |
Active, not recruiting |
NCT06193759 -
Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
|
Phase 1 | |
Suspended |
NCT03904862 -
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
|
Phase 1/Phase 2 | |
Withdrawn |
NCT01697514 -
A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma
|
Phase 1 | |
Recruiting |
NCT05230758 -
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
|
Phase 3 | |
Not yet recruiting |
NCT05406947 -
Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children
|
||
Completed |
NCT02238899 -
Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or Ependymoma
|
N/A | |
Recruiting |
NCT05057702 -
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma
|
N/A | |
Recruiting |
NCT04185038 -
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
|
Phase 1 | |
Terminated |
NCT02624388 -
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
|
Phase 2 |